Quantifying aminoglycoside resistance in extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales clinical isolates: a retrospective cohort study
In a low ESBL endemicity setting, aminoglycoside resistance in patients harbouring ESBL-PE is common, especially ESBL-K. pneumoniae, and needs to be considered in clinicians' decision-making regarding empiric therapy regimens.
Authors
- Isabelle Vock
- Elisabeth Wehrle‐Wieland (ORCID: https://orcid.org/0000-0003-4769-636X)
- Pranita D. Tamma (ORCID: https://orcid.org/0000-0002-4143-6324)
- Sarah Tschudin‐Sutter (ORCID: https://orcid.org/0000-0003-4875-5368)
- Adrian Egli (ORCID: https://orcid.org/0000-0002-3564-8603)
- Nina Khanna (ORCID: https://orcid.org/0000-0002-2642-419X)
- Lisandra Aguilar‐Bultet (ORCID: https://orcid.org/0000-0001-7662-7131)
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- University Hospital of Basel (CH)
Publication Details
- Journal
- Swiss Medical Weekly
- Published
- 2024-10-09
- DOI
- https://doi.org/10.57187/s.3904
- Citations
- 1
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.17
Funders
- Universität Basel
- Universitätsspital Basel
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung